Abstract

Objective To investigate the relationship between miRNAs and the recurrence of hepatocellular carcinoma (HCC) after liver transplantation in Wistar rats and the significance. Methods A small and superficial incision into the left lateral lobe of male Wistar rats was made. A 0.5-1.0 mm cube of walker-256 carcinosarcoma fragments was implanted into the 1iver incision. The rat model of HCC was established, and the liver transplantation model was established after 2 weeks. Three weeks after transplantation, the Wistar rats after liver transplantation were divided into 2 groups: no recurrence group (group A) and recurrence group (group B). The survival rate and recurrence were observed 3 weeks after liver transplantation. The liver tissues and HCC tissues in both two groups were obtained. The real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-192, miR-122, miR-146a and miR-148a in both two groups.. Results The presence of solitary tumor was 100% at 2nd week in the intrahepatic tumor implantation model, and the orthotopic liver transplantation (OLT) of recipients was done. The 3-week cumulative survival rate after OLT was 76.5%. The relative expression of miR-192 was higher, and that of miR-122, miR-146a and miR-148a was lower in the recurrence group than in the non-recurrence group with the difference being statistically significant. Conclusion Our study, in addition to suggesting a different miRNA expression pattern between HCC samples of rats with recurrence and those with non-recurrence, proposes miR-192, miR-122, miR-146a and miR-148a may serve as biomarkers for prognosis of HCC recipients following OLT. Key words: Rats; Hepatocellular carcinoma; Liver transplantation; Animal model; miRNA; Recurrence

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call